Immune checkpoint inhibitor for hepatocellular carcinoma recurrence after liver transplantation

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Brain Neoplasms / secondary
• Carcinoma, Hepatocellular / drug therapy*
• Carcinoma, Hepatocellular / secondary
• Carcinoma, Hepatocellular / surgery
• Carcinoma, Hepatocellular / virology
• Chemoembolization, Therapeutic
• Fatal Outcome
• Hepatectomy
• Humans
• Immune Checkpoint Inhibitors / therapeutic use*
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / pathology
• Liver Neoplasms / surgery
• Liver Neoplasms / virology
• Liver Transplantation / adverse effects*
• Lung Neoplasms / secondary
• Lung Neoplasms / therapy
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy*
• Neoplasm Recurrence, Local / etiology
• Programmed Cell Death 1 Receptor / antagonists & inhibitors